On April 25, Clarus Therapeutics Holdings Inc. (CRXT) priced an upsized underwritten public offering of its common stock, and warrants. The news had the stock tumble
Clarus Therapeutics Holdings, Inc. (CRXT) is a biotherapeutics firm engaged in the development of androgen and metabolic therapeutics for both the sex. The company develops potential
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.